In this podcast episode, Ciro Rinaldi MD, PhD, and Alessandro M. Vannucchi, MD, discuss contemporary management of essential thrombocythemia (ET) and polycythemia vera (PV), as well as novel investigational approaches, including the following: Overview of current treatment paradigms for PV and ET Importance of shared decision-making and patient communication in determining treatment Current therapeutic areas of need in ET and PV Emerging investigational therapeutics Presenters: Ciro Rinaldi MD, PhD Chief Medical Officer, United Lincolnshire Teaching Hospital Honorary Professor of Haematology, University of Lincoln Honorary Professor De Montfort University Dubai Consultant Haematologist Lincoln, United Kingdom Alessandro M. Vannucchi, MD Professor of Hematology University of Florence Director of Hematology Department Director of Oncology Department Azienda Ospedaliera Universitaria Careggi Florence, Italy Content based on an online CME program supported by an educational grant from Merck. Link to full program:https://bit.ly/4u09lKd Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related